Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Operating Expenses (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Operating Expenses for 11 consecutive years, with $73.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 21.27% year-over-year to $73.7 million, compared with a TTM value of $258.1 million through Dec 2025, up 18.02%, and an annual FY2025 reading of $258.1 million, up 18.02% over the prior year.
  • Operating Expenses was $73.7 million for Q4 2025 at Wave Life Sciences, up from $64.0 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $73.7 million in Q4 2025 and bottomed at $37.9 million in Q4 2021.
  • Average Operating Expenses over 5 years is $49.6 million, with a median of $45.2 million recorded in 2022.
  • The sharpest move saw Operating Expenses dropped 19.73% in 2021, then increased 27.32% in 2024.
  • Year by year, Operating Expenses stood at $37.9 million in 2021, then grew by 18.29% to $44.8 million in 2022, then grew by 6.55% to $47.7 million in 2023, then rose by 27.32% to $60.8 million in 2024, then rose by 21.27% to $73.7 million in 2025.
  • Business Quant data shows Operating Expenses for WVE at $73.7 million in Q4 2025, $64.0 million in Q3 2025, and $61.5 million in Q2 2025.